Symptoms, Causes, and Management

Why some people react badly to fermented foods, wine, and aged cheese — and what to do about it

Histamine intolerance affects an estimated 1–3% of people, though many more go undiagnosed for years. It happens when histamine — a compound naturally found in many foods — accumulates in your body faster than you can break it down. The result can be headaches, flushing, hives, digestive upset, nasal congestion, and heart palpitations after eating foods most people tolerate easily [1]. Unlike a food allergy, which is an immune system reaction, histamine intolerance is an enzyme capacity problem — and it's often treatable with dietary changes and targeted support.

What Histamine Intolerance Actually Is

Histamine is a biologically active compound with roles in immune signaling, stomach acid production, neurotransmission, and local tissue responses. Your body produces some itself, and you also get it from food.

The primary enzyme responsible for breaking down dietary histamine is diamine oxidase (DAO), produced by cells lining the small intestine. When DAO activity is sufficient, histamine from food is degraded in the gut before it enters circulation. When DAO is deficient or overwhelmed, histamine passes into the bloodstream and activates receptors throughout the body — triggering a range of symptoms [1].

This is fundamentally different from a histamine allergy. An allergy involves the immune system producing IgE antibodies after sensitization to a specific trigger. Histamine intolerance requires no sensitization, no prior exposure, and no immune response — it's dose-dependent, and symptoms appear in proportion to how much histamine you consume relative to your enzyme capacity [2].

How DAO Deficiency Develops

DAO deficiency can arise from three sources [2]:

Genetic: Variants in the AOC1 gene (which encodes the DAO enzyme) reduce how much functional DAO you produce. These single nucleotide polymorphisms are relatively common and explain why histamine intolerance can run in families.

Intestinal damage: DAO is made in intestinal epithelial cells. Conditions that damage the gut lining — Crohn's disease, celiac disease, SIBO, chronic infections — can reduce DAO output significantly. This is why histamine intolerance often develops after a period of gut illness and can improve when the underlying gut condition is treated [8].

Medications: Many common drugs inhibit DAO activity, including alcohol, certain antibiotics, antidepressants (especially MAO inhibitors), NSAIDs, and some antacids. If you're taking these and experiencing histamine-like symptoms, medication effect may be a contributing factor [2].

Symptoms: Why They're So Varied

Histamine acts on four receptor subtypes distributed throughout the body. This is why histamine intolerance produces such a wide and seemingly unconnected symptom picture [4]:

H1 receptors (skin, airways, brain): urticaria (hives), flushing, itching, sneezing, rhinorrhea, bronchospasm, headache, dizziness
H2 receptors (stomach): excess acid, bloating, abdominal pain, diarrhea, heartburn
H1 + H2 (cardiovascular): low blood pressure, heart palpitations, irregular heartbeat
Central H1: brain fog, difficulty concentrating, sleep disruption, anxiety

In one cohort of histamine intolerance patients, bloating was present in 92% of subjects, dizziness in 66%, headache in 65%, palpitations in 47%, and itching in 48%. An average of 11 different symptoms per patient was recorded [4]. Many people are diagnosed with IBS, anxiety, or chronic migraine before histamine intolerance is considered.

High-Histamine Foods to Reduce or Eliminate

The foods highest in histamine are fermented, aged, smoked, or preserved — processes that allow bacteria to convert the amino acid histidine into histamine [1]:

Very high in histamine:

Fermented foods: sauerkraut, kimchi, kefir, kombucha, aged vinegar
Aged cheeses: cheddar, parmesan, brie, camembert
Cured and processed meats: salami, pepperoni, prosciutto, hot dogs
Smoked and canned fish: tuna, sardines, anchovies, mackerel
Alcoholic beverages, especially red wine and beer

DAO-blocking foods (don't contain much histamine but block your ability to break it down):

Alcohol
Energy drinks
Black and green tea in large amounts

Histamine-liberating foods (trigger mast cells to release histamine even without containing it):

Tomatoes, citrus fruits, strawberries
Spinach, eggplant, avocado
Nuts (especially walnuts and cashews)
Chocolate and cocoa
Food additives: artificial colorings, sulfites, benzoates

In a clinical trial by Wantke and Jarisch, 45 patients with food intolerance or chronic headaches followed a histamine-restricted diet for four weeks. 33 of 45 showed considerable improvement, and 8 achieved complete remission. Headache frequency, duration, and intensity all decreased significantly (p<0.001) [7].

Supporting Your DAO Enzyme

DAO is a copper-containing enzyme that also requires other cofactors to function properly [4]:

Copper — structural component of DAO; deficiency reduces enzyme activity
Vitamin B6 (pyridoxal phosphate) — required for DAO's catalytic function; plasma DAO activity correlates directly with B6 status [10]
Vitamin C — supports DAO synthesis and aids histamine clearance through a separate metabolic pathway
Zinc — supporting role in enzyme activity

If your diet is low in these nutrients, addressing deficiencies may improve histamine clearance capacity. Organ meats (liver), seeds, legumes, and leafy greens are good food sources.

DAO Supplementation

Oral DAO supplements (typically derived from pea-sprout extract or kidney protein) are designed to be taken just before meals to supplement the enzyme in the gut. Several trials have produced encouraging results.

In an 8-week pilot study, 28 confirmed histamine intolerance patients took DAO capsules before meals for four weeks, then stopped. All 22 tracked symptoms improved significantly during supplementation, and scores rose again after the four-week washout period [6].

More compellingly, a randomized double-blind trial of 100 migraine patients with confirmed DAO deficiency found that DAO supplementation reduced migraine duration from 6.14 to 4.76 hours — a 1.4-hour reduction — while the placebo group showed minimal change. Triptan use decreased only in the DAO group [5].

Supplemental DAO does not cure the underlying deficiency but acts as a buffer, giving your gut more enzyme capacity to handle histamine in a meal.

The Gut Connection

Because DAO is produced in the intestinal lining, gut health is central to histamine management. Intestinal damage reduces DAO output; a healthier gut lining means more DAO [8].

There is also a direct microbiome link. A 2022 study comparing gut bacteria in histamine intolerance patients versus healthy controls found that HIT patients had significantly lower populations of beneficial bacteria like Faecalibacterium prausnitzii and Ruminococcus (both anti-inflammatory and important for gut barrier integrity), and 7x higher levels of Staphylococcus and elevated Clostridium perfringens — both histamine-producing genera [9]. The dysbiosis doesn't just damage the gut lining; it actively generates more histamine from inside.

This suggests that improving gut microbiome health — through probiotic-rich foods (with attention to histamine content), prebiotics, and removing gut irritants — may reduce histamine load from within, not just from diet.

See our Leaky Gut page for more on gut lining repair, and our Probiotics page for microbiome support strategies.

Histamine Intolerance vs. MCAS

Mast cell activation syndrome (MCAS) can look almost identical to histamine intolerance. In MCAS, the mast cells themselves are dysfunctional — they spontaneously degranulate and release histamine along with other mediators including tryptase, prostaglandins, and leukotrienes. In histamine intolerance, mast cells function normally; the problem is insufficient enzyme to clear the dietary histamine load [3].

The two conditions share symptoms so thoroughly that clinical presentation alone cannot distinguish them. Some patients have both simultaneously, making each worse. If symptoms are severe, persistent, or accompanied by anaphylaxis-like reactions, evaluation for MCAS by an allergist is warranted alongside a standard histamine intolerance workup [3].

How Histamine Intolerance Is Diagnosed

There is currently no universally accepted diagnostic standard [3]. The current approach combines:

Symptom questionnaire — validated tools that score symptom pattern, frequency, and relationship to meals
Serum DAO measurement — values below 80 HDU/ml are commonly used as a threshold for deficiency
Low-histamine elimination diet — 4–6 weeks, with symptom diary; improvement supports diagnosis
Oral histamine challenge — conducted under medical supervision to confirm the relationship
AOC1 genetic testing — emerging; identifies gene variants associated with reduced DAO production

Symptom improvement on a low-histamine diet remains the most practical diagnostic approach for most people.

Evidence Review

Foundational Science

The landmark 2007 review by Maintz and Novak (PMID 17490952) established the scientific framework for histamine intolerance as a distinct entity. They defined it as "a disequilibrium of accumulated histamine and the capacity for histamine degradation" — distinguishing it explicitly from IgE-mediated allergy. Their review documented the full symptom spectrum, catalogued high-histamine foods with supporting data, and identified DAO and HNMT (histamine N-methyltransferase) as the two primary histamine-metabolizing enzymes. DAO handles extracellular histamine (primarily from food in the gut lumen); HNMT handles intracellular histamine. This paper remains the most-cited foundational reference in the field.

A 2020 comprehensive review by Comas-Basté et al. (PMID 32824107, Biomolecules) clarified the three etiological origins of DAO deficiency: genetic (AOC1 gene SNPs), pathological (gut disease damaging DAO-producing epithelial cells), and pharmacological (drug inhibition). They reported that in some cohorts, combinations of three or more multi-organ symptoms were recorded in 97% of patients, with an average of 11 symptoms per patient — explaining why HIT is so often misdiagnosed. They also surveyed low-histamine diet studies showing symptom improvement rates of 33–100%, though noting significant variation in study quality and design.

Dietary Intervention Evidence

The clinical foundation for low-histamine diet comes partly from Wantke, Götz, and Jarisch (PMID 10779289, Clin Exp Allergy 1993). Their study of 45 patients — 17 with food/wine intolerance and 28 with chronic headaches — found that 4 weeks of histamine-restricted diet produced significant improvement in 33 patients (p<0.01) and complete remission in 8. Headache frequency, duration, and intensity all decreased (p<0.001). Foods eliminated included fermented vegetables, aged cheeses, cured meats, alcoholic beverages, and canned fish. This study by two of the field's pioneers established histamine restriction as the primary treatment for confirmed HIT.

DAO Supplementation Trials

Izquierdo-Casas et al. (2019, PMID 29475774) conducted the most methodologically rigorous supplementation trial to date: a randomized, double-blind, placebo-controlled study of 100 episodic migraine patients with confirmed DAO deficiency (below 80 HDU/ml). The DAO group received enzyme capsules before meals; the control group received placebo. Primary outcome: migraine episode duration. DAO group: reduced from 6.14 to 4.76 hours (−22.5%). Placebo group: 7.53 to 6.68 hours (−11.3%). The difference was statistically significant. Secondary outcomes: triptan use decreased only in the DAO group. No adverse effects were observed. Limitation: the supplement manufacturer was not involved in study design or analysis, which strengthens the result.

Schnedl et al. (2019, PMID 31807350) conducted an open-label pilot study of 28 confirmed HIT patients over 8 weeks: 4 weeks of DAO supplementation before meals, 4-week washout. All 22 tracked symptoms — including bloating, diarrhea, abdominal cramps, skin flushing, urticaria, rhinorrhea, and headache — improved significantly during supplementation. After washout, scores rose again toward baseline. This crossover design controls for regression to the mean and demonstrates clear supplement-dependent effects. Limitation: some authors had financial relationships with the supplement manufacturer (Sciotec), which introduces potential bias.

Gut Microbiome Research

Sánchez-Pérez et al. (2022, PMID 35565742, Nutrients) performed 16S rRNA gut microbiome sequencing in HIT patients versus healthy controls. HIT patients showed significantly reduced Prevotellaceae, Ruminococcus, Faecalibacterium prausnitzii, and related taxa — bacteria associated with short-chain fatty acid production, intestinal barrier integrity, and anti-inflammatory signaling. Simultaneously, histaminogenic genera were elevated: Staphylococcus (7x higher), Proteus (1.8x higher), Clostridium perfringens, and Enterococcus faecalis. The authors concluded that "greater abundance of histaminogenic bacteria would favor the accumulation of high levels of histamine in the gut" — creating a self-reinforcing cycle where dysbiosis increases histamine load while simultaneously damaging the DAO-producing epithelium.

Schink et al. (2018, PMID 30552302) compared gut microbiota across four groups: HIT patients, food hypersensitivity, food allergy, and healthy controls. HIT patients showed increased Proteobacteria (5.4%) and reduced alpha-diversity. Bifidobacteriaceae were lowest in the HIT group compared to healthy controls. Stool zonulin — a marker of intestinal permeability ("leaky gut") — was elevated in HIT patients, suggesting that barrier dysfunction may both result from and contribute to histamine intolerance.

Schnedl and Enko (2021, PMID 33921522, Nutrients) synthesized this evidence into a gut-origin framework for HIT, arguing that it should be understood primarily as a gastrointestinal disorder. DAO is produced in intestinal epithelial cells; gut damage reduces DAO output; concurrent GI conditions (SIBO, IBS, celiac) amplify histamine load. This framework explains why HIT so frequently co-occurs with other gut diagnoses and why gut-targeted treatment (not just dietary restriction) may be necessary for lasting improvement.

Diagnostic Evidence

Music et al. (2011, PMC3354134) studied serum DAO activity in 316 patients with HIT-associated symptoms versus 20 healthy controls. DAO activity was significantly lower in patients (p<0.0001). Of the 316 patients, 80% had DAO deficiency. Among 20 patients with severely reduced DAO (<40 HDU/ml) who followed a histamine-restricted diet for 6–12 months, both symptom resolution and recovery of enzyme activity were observed — suggesting that dietary intervention may allow the gut epithelium to recover. This study established serum DAO measurement as a useful adjunct diagnostic tool.

Cofactor Evidence

Martner-Hewes et al. (1986, PMID 3098085) demonstrated a direct correlation between vitamin B6 nutritional status and plasma DAO activity. DAO is a pyridoxal phosphate-dependent enzyme; B6 deficiency impairs its catalytic function. The study used a pregnancy cohort where DAO is naturally elevated, but the biochemical dependence applies broadly. Combined with copper's structural role in DAO (as a copper-containing amine oxidase) and vitamin C's supporting role in histamine clearance via methylation pathways, this establishes a nutritional dimension to histamine intolerance that can be addressed through diet and supplementation.

Evidence Strength Assessment

The evidence for low-histamine diet is moderate: multiple small clinical trials and case series showing consistent symptom improvement, but few large randomized controlled trials with standardized outcomes.

The evidence for DAO supplementation is moderate to promising: one reasonably well-designed RCT in migraineurs (PMID 29475774) and a pilot study showing reversible effects (PMID 31807350), tempered by some conflicts of interest in the supplementation literature.

The evidence for gut microbiome involvement is early but biologically coherent: observational studies showing consistent dysbiosis patterns (elevated histaminogenic bacteria, reduced barrier-protective bacteria) support a mechanistic link, but intervention trials targeting the microbiome in HIT specifically are limited.

The evidence for DAO cofactor supplementation (B6, copper, vitamin C) improving HIT is indirect — based on enzyme biochemistry and nutrient depletion studies — rather than direct clinical trials in HIT populations. The potential for benefit is real; the magnitude is unknown.

References

Histamine and histamine intoleranceMaintz L, Novak N. American Journal of Clinical Nutrition, 2007. PubMed 17490952 →
Histamine Intolerance: The Current State of the ArtComas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, Latorre-Moratalla M, Vidal-Carou MC. Biomolecules, 2020. PubMed 32824107 →
Histamine Intolerance—The More We Know the Less We Know. A ReviewHrubisko M, Danis R, Huorka M, Wawruch M. Nutrients, 2021. PubMed 34209583 →
Histamine Intolerance: Symptoms, Diagnosis, and BeyondJochum C. Nutrients, 2024. PubMed 38674909 →
Diamine oxidase (DAO) supplement reduces headache in episodic migraine patients with DAO deficiency: A randomized double-blind trialIzquierdo-Casas J, Comas-Basté O, Latorre-Moratalla ML, Lorente-Gascón M, Delgado-Batlle J, Vidal-Carou MC. Clinical Nutrition, 2019. PubMed 29475774 →
Diamine oxidase supplementation improves symptoms in patients with histamine intoleranceSchnedl WJ, Schenk M, Lackner S, Enko D, Mangge H, Forster F. Food Science and Biotechnology, 2019. PubMed 31807350 →
Histamine-free diet: treatment of choice for histamine-induced food intolerance and supporting treatment for chronic headachesWantke F, Götz M, Jarisch R. Clinical and Experimental Allergy, 1993. PubMed 10779289 →
Histamine Intolerance Originates in the GutSchnedl WJ, Enko D. Nutrients, 2021. PubMed 33921522 →
Intestinal Dysbiosis in Patients with Histamine IntoleranceSánchez-Pérez S, Comas-Basté O, Duelo A, Veciana-Nogués MT, Berlanga M, Latorre-Moratalla ML, Vidal-Carou MC. Nutrients, 2022. PubMed 35565742 →
Vitamin B-6 nutriture and plasma diamine oxidase activity in pregnant Hispanic teenagersMartner-Hewes PM, Hunt IF, Murphy NJ, Swendseid ME, Settlage RH. American Journal of Clinical Nutrition, 1986. PubMed 3098085 →